BR112014012882A2 - método, anticorpo, polinucleotídeo, célula hospedeira, linhagem celular de hibridoma, uso do anticorpo e kit - Google Patents
método, anticorpo, polinucleotídeo, célula hospedeira, linhagem celular de hibridoma, uso do anticorpo e kitInfo
- Publication number
- BR112014012882A2 BR112014012882A2 BR112014012882A BR112014012882A BR112014012882A2 BR 112014012882 A2 BR112014012882 A2 BR 112014012882A2 BR 112014012882 A BR112014012882 A BR 112014012882A BR 112014012882 A BR112014012882 A BR 112014012882A BR 112014012882 A2 BR112014012882 A2 BR 112014012882A2
- Authority
- BR
- Brazil
- Prior art keywords
- antibody
- polynucleotide
- kit
- host cell
- cell line
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y116/00—Oxidoreductases oxidizing metal ions (1.16)
- C12Y116/01—Oxidoreductases oxidizing metal ions (1.16) with NAD+ or NADP+ as acceptor (1.16.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03048—Protein-tyrosine-phosphatase (3.1.3.48)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4742—Keratin; Cytokeratin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90287—Oxidoreductases (1.) oxidising metal ions (1.16)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4915—Blood using flow cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161629886P | 2011-11-29 | 2011-11-29 | |
US201261703099P | 2012-09-19 | 2012-09-19 | |
PCT/US2012/066998 WO2013082249A2 (en) | 2011-11-29 | 2012-11-29 | Compositions and methods for prostate cancer analysis |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014012882A2 true BR112014012882A2 (pt) | 2017-06-13 |
Family
ID=47324459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014012882A BR112014012882A2 (pt) | 2011-11-29 | 2012-11-29 | método, anticorpo, polinucleotídeo, célula hospedeira, linhagem celular de hibridoma, uso do anticorpo e kit |
Country Status (15)
Country | Link |
---|---|
US (2) | US20130143237A1 (pt) |
EP (1) | EP2786151B1 (pt) |
JP (1) | JP6219304B2 (pt) |
KR (1) | KR101951514B1 (pt) |
CN (1) | CN104067127A (pt) |
AR (1) | AR089028A1 (pt) |
AU (1) | AU2012345926A1 (pt) |
BR (1) | BR112014012882A2 (pt) |
CA (1) | CA2854042A1 (pt) |
IL (1) | IL232466A (pt) |
MX (1) | MX350807B (pt) |
RU (1) | RU2641968C2 (pt) |
SG (1) | SG11201402711SA (pt) |
WO (1) | WO2013082249A2 (pt) |
ZA (1) | ZA201403110B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105646661A (zh) * | 2014-03-24 | 2016-06-08 | 朱育盼 | 特异性结合前列腺癌的短肽pcp2及其应用 |
WO2016172160A1 (en) * | 2015-04-21 | 2016-10-27 | Genentech, Inc. | Compositions and methods for prostate cancer analysis |
PE20200010A1 (es) | 2017-04-03 | 2020-01-06 | Hoffmann La Roche | Anticuerpos que se unen a steap-1 |
CN108179134B (zh) * | 2017-12-27 | 2020-11-24 | 武汉大学 | 基于EpCAM/PSMA双抗体功能化微流控芯片及其制备方法和应用 |
MX2021000163A (es) | 2018-07-02 | 2021-05-27 | Amgen Inc | Proteina de union al antigeno anti-steap1. |
CA3150149A1 (en) * | 2019-09-05 | 2021-03-11 | Memorial Sloan Kettering Cancer Center | ANTI-STEAP1 ANTIBODIES AND THEIR USES |
BR102020013625A2 (pt) * | 2020-07-02 | 2022-01-11 | Universidade Federal de Uberlândia | Aptâmero modificado, sistema aptaimunológico, painel aptaimunológico, kit, método e uso no diagnóstico de câncer de próstata |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
US5597531A (en) | 1985-10-04 | 1997-01-28 | Immunivest Corporation | Resuspendable coated magnetic particles and stable magnetic particle suspensions |
EP0368684B2 (en) | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
US5698271A (en) | 1989-08-22 | 1997-12-16 | Immunivest Corporation | Methods for the manufacture of magnetically responsive particles |
US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
GB9114948D0 (en) | 1991-07-11 | 1991-08-28 | Pfizer Ltd | Process for preparing sertraline intermediates |
CA2116774C (en) | 1991-09-19 | 2003-11-11 | Paul J. Carter | Expression in e. coli antibody fragments having at least a cysteine present as a free thiol. use for the production of bifunctional f(ab') 2 antibodies |
US5587458A (en) | 1991-10-07 | 1996-12-24 | Aronex Pharmaceuticals, Inc. | Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
CA2372813A1 (en) | 1992-02-06 | 1993-08-19 | L.L. Houston | Biosynthetic binding protein for cancer marker |
US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
US6046048A (en) * | 1996-01-09 | 2000-04-04 | Genetech, Inc. | Apo-2 ligand |
US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
DE69941689D1 (de) | 1998-02-12 | 2010-01-07 | Univ Texas | Verfahren und reagenzien zur raschen und effizienten isolierung zirkulierender krebszellen |
US6200765B1 (en) * | 1998-05-04 | 2001-03-13 | Pacific Northwest Cancer Foundation | Non-invasive methods to detect prostate cancer |
JP4855577B2 (ja) | 1998-06-01 | 2012-01-18 | アジェンシス,インコーポレイテッド | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
IL129299A0 (en) * | 1999-03-31 | 2000-02-17 | Mor Research Applic Ltd | Monoclonal antibodies antigens and diagnosis of malignant diseases |
MXPA02003456A (es) | 1999-10-04 | 2002-10-23 | Medicago Inc | Metodo para regular la transcripcion de genes foraneos. |
US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
BR0207290A (pt) | 2001-02-16 | 2005-06-07 | Immunivest Corp | Método para analisar um paciente quanto à presença de uma malignidade, célula maligna isolada das células cultivadas, vacina de tumor, molécula associada com diátese de tumor alterada, métodos para determinar alterações em moléculas associadas com diátese de tumor como um meio para predizer a eficácia da terapia, como um meio para analisar dosagem apropriada para terapia, como um meio para monitorar eficácia da terapia, como um meio para analisar progressão de câncer, para realizar uma biópsia de corpo inteiro em um paciente, e para identificar alterações em uma célula de tumor circulante relativamente a células presentes numa massa de tumor in situ, e, kit de teste para analisar uma amostra de paciente quanto à presença de uma célula maligna não-hematopoiética |
US20030190602A1 (en) | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
US7219016B2 (en) * | 2001-04-20 | 2007-05-15 | Yale University | Systems and methods for automated analysis of cells and tissues |
US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
MXPA06012187A (es) * | 2004-04-22 | 2007-03-28 | Agensys Inc | Anticuerpos y moleculas derivadas de estas que se enlazan a las proteinas steap-1. |
US20100111856A1 (en) | 2004-09-23 | 2010-05-06 | Herman Gill | Zirconium-radiolabeled, cysteine engineered antibody conjugates |
KR101541550B1 (ko) * | 2006-10-27 | 2015-08-04 | 제넨테크, 인크. | 항체 및 면역접합체 및 이들의 용도 |
US20100129804A1 (en) * | 2006-11-08 | 2010-05-27 | Chinnaiyan Arul M | Spink1 as a prostate cancer marker and uses thereof |
JP5394246B2 (ja) * | 2007-03-30 | 2014-01-22 | ジェネンテック, インコーポレイテッド | 抗体及びイムノコンジュゲートとこれらの使用方法 |
WO2010028160A1 (en) * | 2008-09-05 | 2010-03-11 | The Scripps Research Institute | Methods for the detection of circulating tumor cells |
US20110287038A1 (en) * | 2010-04-16 | 2011-11-24 | Kevin Slawin | Method for treating solid tumors |
-
2012
- 2012-11-29 BR BR112014012882A patent/BR112014012882A2/pt not_active Application Discontinuation
- 2012-11-29 JP JP2014544870A patent/JP6219304B2/ja active Active
- 2012-11-29 CA CA2854042A patent/CA2854042A1/en not_active Abandoned
- 2012-11-29 KR KR1020147017563A patent/KR101951514B1/ko active IP Right Grant
- 2012-11-29 MX MX2014006187A patent/MX350807B/es active IP Right Grant
- 2012-11-29 SG SG11201402711SA patent/SG11201402711SA/en unknown
- 2012-11-29 CN CN201280067510.XA patent/CN104067127A/zh active Pending
- 2012-11-29 WO PCT/US2012/066998 patent/WO2013082249A2/en active Application Filing
- 2012-11-29 US US13/689,407 patent/US20130143237A1/en not_active Abandoned
- 2012-11-29 AR ARP120104485A patent/AR089028A1/es unknown
- 2012-11-29 RU RU2014126358A patent/RU2641968C2/ru not_active IP Right Cessation
- 2012-11-29 AU AU2012345926A patent/AU2012345926A1/en not_active Abandoned
- 2012-11-29 EP EP12798559.6A patent/EP2786151B1/en active Active
-
2014
- 2014-04-29 ZA ZA2014/03110A patent/ZA201403110B/en unknown
- 2014-05-05 IL IL232466A patent/IL232466A/en not_active IP Right Cessation
-
2015
- 2015-10-21 US US14/919,388 patent/US9632091B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
SG11201402711SA (en) | 2014-06-27 |
US9632091B2 (en) | 2017-04-25 |
CA2854042A1 (en) | 2013-06-06 |
JP6219304B2 (ja) | 2017-10-25 |
MX2014006187A (es) | 2014-06-23 |
CN104067127A (zh) | 2014-09-24 |
EP2786151A2 (en) | 2014-10-08 |
US20130143237A1 (en) | 2013-06-06 |
US20160274116A1 (en) | 2016-09-22 |
RU2014126358A (ru) | 2016-01-27 |
MX350807B (es) | 2017-09-20 |
JP2015507175A (ja) | 2015-03-05 |
IL232466A (en) | 2017-10-31 |
KR101951514B1 (ko) | 2019-02-22 |
ZA201403110B (en) | 2017-06-28 |
WO2013082249A3 (en) | 2013-10-10 |
EP2786151B1 (en) | 2019-07-03 |
KR20140100544A (ko) | 2014-08-14 |
AU2012345926A1 (en) | 2014-05-29 |
AR089028A1 (es) | 2014-07-23 |
RU2641968C2 (ru) | 2018-01-23 |
WO2013082249A2 (en) | 2013-06-06 |
IL232466A0 (en) | 2014-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1217971A1 (zh) | 用於核酸分析的方法、組合物和試劑盒 | |
HK1206774A1 (en) | Biophotonic compositions, kits and methods | |
AR089178A1 (es) | Anticuerpos anti-il-36r | |
DK2606145T3 (da) | Fremgangsmåder til bestemmelse af antibiotikaresistens i mikroorganismer | |
DK3327141T3 (da) | Fremgangsmåde til identificering af den cellulære sammensætning i en biologisk prøve | |
BR112014012882A2 (pt) | método, anticorpo, polinucleotídeo, célula hospedeira, linhagem celular de hibridoma, uso do anticorpo e kit | |
EP3026108A4 (en) | Cell culturing method, cell culturing apparatus and kit | |
EP2895591A4 (en) | INTEGRATED MICROFLUIDIC SYSTEM, METHOD AND KIT FOR PERFORMING TESTS | |
CL2015001266A1 (es) | Anticuerpos de antihemaglutinina y métodos de uso. | |
CO6870005A2 (es) | Composición anti-cgrp y uso de las mismas | |
BR112014018136A2 (pt) | anticorpos ou uso e método para determinar | |
BR112012031232A2 (pt) | método, dispositivo e uso | |
BRPI1010798A2 (pt) | fechamento, aparelho de retenção, e método de uso do mesmo | |
HK1210522A1 (en) | Bladder cancer detection composition kit, and associated methods | |
DK2732260T3 (da) | Prøveopsamlingskit | |
ITRM20120383A1 (it) | Metodo e kit per la rivelazione di anticorpi. | |
HK1222180A1 (zh) | 用於生物樣品中的具有提高的性能的 測定 | |
BRPI1006996A2 (pt) | composição, método e uso | |
EP2696202A4 (en) | SQUIRREL TEST TESTING METHOD AND PANCREATIC TEST TEST KIT | |
BR112014008088A2 (pt) | método para detectar anticorpos, uso de um método, e, kit | |
BR112013012450A2 (pt) | composições, métodos de detecção e kits | |
ES2609638T8 (es) | Poración celular | |
BR112016009753A2 (pt) | método de cultura de células. | |
WO2013181576A3 (en) | Methods of evaluating and making biologics | |
BR112014017802A2 (pt) | antígeno, molécula, vetor, célula hospedeira, método de produção de um antígeno, composição, método para detectar, uso de um antígeno e kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |